An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates

AIM: To establish the responses to the Sinopharm HB02 COVID‐19 vaccination in the dialysis population, which are not well established. We examined the humoral responses to the Sinopharm COVID vaccine in haemodialysis patients. METHODS: Standard vaccinations (two doses at interval of ~21 days) were g...

Descripción completa

Detalles Bibliográficos
Autores principales: Holt, Stephen Geoffrey, Mahmoud, Sally, Ahmed, Wasim, Acuna, Juan Manuel, Al Madani, Ayman Kamal, Eltantawy, Islam, Zaher, Walid Abbas, Goodier, Gareth John, Al Kaabi, Nawal Ahmed, Al Obaidli, Ali Abdulkareem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Dialysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646272/
https://www.ncbi.nlm.nih.gov/pubmed/34569677
http://dx.doi.org/10.1111/nep.13980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646272/
https://www.ncbi.nlm.nih.gov/pubmed/34569677
http://dx.doi.org/10.1111/nep.13980

Ejemplares similares